1 completed, 1 unknown. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Unknown 1 |
Follow Conjunctival Scarring: new trials by email Literature Review of Conjunctival Scarring trials Research Report on Conjunctival Scarring
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Digital Colorimetric Scale for Recurrent Pterygium Scar Assessment Recurrent Pterygium, Conjunctival Scarring | Completed | Instituto de Oftalmología Fundación Conde de Valenciana | 25 | 2024-08-22 | 2026-03-09 | |
| Bleb Vascularity Change After Subconjunctival Injection Bevacizumab bevacizumab - Bleb Vascularity, Conjunctival Scarring | Phase 4 | Unknown | Capital Medical University | 30 | 2008-12-01 | 2008-12-30 |
Conjunctival Diseases (1) · Eye Diseases (1) · Pathological Conditions, Anatomical (1) · Pathological Conditions, Signs and Symptoms (1) · Skin Diseases (1) · Skin Diseases, Vesiculobullous (1) · Skin and Connective Tissue Diseases (1)
Bevacizumab (1)
Capital Medical University (1) · Instituto de Oftalmología Fundación Conde de Valenciana (1)
China (1) · Mexico (1)
Jose Adrian Negrete, MD (1) · Liu Xuan, M.D. (1)